Vitalhub (TSE:VHI) Price Target Raised to C$12.50 at Canaccord Genuity Group

Vitalhub (TSE:VHI) had its price objective raised by Canaccord Genuity Group from C$12.00 to C$12.50 in a research note published on Thursday morning,BayStreet.CA reports. The firm currently has a buy rating on the stock.

VHI has been the topic of several other reports. Cormark increased their target price on Vitalhub from C$9.50 to C$10.50 and gave the stock a “buy” rating in a research report on Wednesday, October 2nd. TD Securities raised Vitalhub to a “strong-buy” rating in a research note on Monday, November 25th. Four investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, Vitalhub presently has a consensus rating of “Buy” and an average target price of C$10.05.

Vitalhub Stock Performance

Shares of VHI stock opened at C$10.95 on Thursday. The firm has a market capitalization of C$556.81 million, a price-to-earnings ratio of 99.55, a price-to-earnings-growth ratio of 1.18 and a beta of 1.26. Vitalhub has a one year low of C$4.00 and a one year high of C$12.09. The company has a 50 day moving average price of C$11.11 and a 200 day moving average price of C$9.35.

About Vitalhub

Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.